Summary. The ATP-and sulphonylurea-sensitivity of the ATP-sensitive K-channel was measured in human pancreatic B cells. In inside-out patches, half-maximal inhibition of channel activity was produced by 10 p~mol/l ATP (with 2 mM Mg 2+) and ATP-inhibition was partially antagonised by ADP. A significantly lower sensitivity to ATP was found in whole-cell recordings. Tolbutamide inhibited whole-cell ATPsensitive K-currents half-maximally at 18 ~tmol/l; the sensitivity to tolbutamide ~vas somewhat less in the inside-out patch.
The activity of the ATP-sensitive K-channel is thought to play a central role in the physiological regulation of insulin secretion from the pancreatic B-cell [1, 2] . Studies of rodent B cells and B cell lines have led to the proposal that an increase in the cytosolic ATP/ADP ratio, resulting from glucose metabolism, inhibits channel activity. This produces membrane depolarization and precipitates a chain of events that culminates in insulin secretion.
The channel is also the target for the hypoglycaemic sulphonylureas used clinically in the treatment of Type 2 (non-insulin-dependent) diabetes mellitus. These drugs inhibit channel activity in rodent B cells [3] [4] [5] [6] [7] and thereby stimulate electrical activity and insulin release [8] . It has therefore been suggested that a defect in the regulation of the ATP-sensitive K-channel may be involved in the initial pathology of Type 2 diabetes [9] .
Information about the properties of this channel in man is scarce. We have shown previously that the normal human B-cell possesses a K-channel inhibited by both ATP and the sulphonylurea, tolbutamide [9] . A similar channel is also found in human insulinoma ceils [10] . In this paper we present a detailed analysis of the properties of the ATP-sensitive K-channel of the human B cell. Our results indicate that the rodent B cell constitutes a good model for that of the human and provide support for the idea that the therapeutic action of tolbutamide in man is mediated via inhibition of the ATP-sensitive K-channel.
Materials and methods

Preparation
Human pancreata were removed (with permission) from nondiabetic, heart-beating cadaw.~r organ donors and islets of Langerhans isolated under aseptic conditions using a method similar to that described previously [11] . "[here were 2 male donors aged 27 and 37, and 3 female donors aged 19, 55 and 58. In brief, the pancreatic duct was cannulated and the pancreas distended with 2 ml/g prewarmed collagenase (6 mg/ml) in Iq[ank's solution. The pancreas was incubated in a water bath at 39~ for 25 rain then cooled rapidly in ice cold Hank's containing 20 mmol/1 HEPES and 5 g/1 bovine serum albumin. The tissue was dispersed by teasing, shaking and gentle syringing, with frequent washing and centrifugation at 50 g for 10 s in this last solution. The dispersed tissue was passed through a 500 ~tm filter, packed by centrifugation at 350 g for 10 s, then underlaid on a multilayered discontinuous Ficoll density gradient of between 1.090 and 1.040. Islets rose to higher levels than exocrine tissue and final islet preparations consisted of between 1,000 and 2,000 islets/g pancreas with purities upwards of 50%. For patch clamp studies, islets were then hand-picked for dissociation into single cells.
This method produced islets that respond to glucose stimulation with dose-dependent increases of glucose oxidation and insulin secretion [12, 13] . Islet identity was confirmed for each B-cell preparation used in this study by dithizone staining, by insulin release in response to glucose perifusion and by light as well as electron microscopy (data not shown). About 80% of islet cells in the adult human pancreas are B cells [14] . Islets were cultured overnight and then dissociated into single cells by collagenase digestion and mechanical dispersion [15] . Cells were maintained for 1-4 days in RPMI 1640 tissue culture medium supplemented with fetal calf serum (10%), penicillin (100 U/ml) and streptomycin (0.1 mg/ml) in a humidified atmosphere of 95% air, 5% CO2 at 37~
Electrophysiology
Standard patch clamp methods were used to record whole-cell currents, and single channel currents from inside-out membrane patches [16] . Pipettes were pulled from borosilicate glass (Rochester Scientific, Rochester, NY, USA), coated with Sylgard close to their tips to reduce their electrical capacitance and fire-polished immediately before use. They had resistances of 3-5 Megaohm when filled with 140 mmol/1 KC1. The reference potential for all measurements was the zero current potential of the pipette before establishment of the seal.
Currents were recorded using a LIST EPC7 patch clamp amplifier (List Electronic, Darmstadt, FRG) and stored on FM tape (Racal Recorders, Hythe, UK) for later analysis; the frequency response of the recording system was 2.5 kHz for whole-cell currents and 10 kHz for single channel currents. The resting potential in whole-cell experiments was measured as the potential at which the pipette current was zero.
No series resistance compensation was used in whole-cell experiments and no corrections have been made for liquid junction potentials (< 5 mV).
F. M. Ashcroft et al.: ATP-sensitive K-channels in man sample frequency (-3db value,). They were then digitised using a 12 bit ADC (Indec, Sunneyvale Calif, USA) controlled by a PDP 11/73 computer (Digital Equipment Corporation-Basingstoke, UK). The sample rate was set at 5 kHz. Probability density histograms were constructed by forming histograms of all digitised data points and expressing the number in each histogram bin as a fraction of the total number of data points sampled. Dose-response curves for nucleotide or tolbutamide inhibition were constructed by measuring the mean current (/) and expressing this as a fraction of its amplitude in control solution (It). I was computed for data lengths of 30 s by integrating the current record after subtraction of the baseline current. The baseline current (i. e. the current level when all channels are closed) was either measured directly (when channel activity was low) or in the presence of 1 mmol/1 ATP. Dose-response relationships for ATP and tolbutamide inhibition were fitted by the function
where [X] is the concentration of inhibitor, n is the slope parameter (Hill co-efficient) and Ki is the concentration at which inhibition is half maximal. In the case of whole-cell currents,/refers to the wholecell current measured in the presence of inhibitor and Ie to the mean of that measured before and after the application of the drug. These values represent the average amplitude of several successive current responses which were measured directly from a digital oscilloscope once a stable current level was obtained.
For some figures the records were subsequently replayed onto a Gould 2200 (Gould, Cleveland, Ohio, USA) chart recorder which has a frequency response of 150 Hz.
Solutions
During whole-cell experiments the bath contained extracellular solution (solution A, in mmol/1): 135 NaC1, 5 KC1, 5 CaC12, 2 MgSO4, 5 HEPES (titrated to pH 7.4 with NaOH). The pipette was filled with an intracellular solution (B, in mmol/l): 107 KC1, 2 MgSO4, 1 CaC12, 11 Ethylene-glycol-bis(13-aminoethyl Ether) N,N,N',N',-Tetraacetic Acid (EGTA:0.06 l.tM free Ca2+), It HEPES (titrated to pH7.2 with KOH; additional K + about 30mmol/l). In most experiments, 0.3 mmol/1 ATP (disodium salt) was included in the pipette solution; in rodent B-cells this concentration of ATP blocks ATP-sensitive K-currents only slightly in whole-cell recordings [5] but prevents rundown of channel activity [5] and maintains the sensitivity to tolbutamide [20] . Tolbutamide was dissolved in NaOH and solutions containing tolbutamide were made fresh each day.
For inside-out patch recordings the pipette was filled with a high K + extracellular solution (solution C) in which KC1 replaced NaC1; the bath contained intracellular solution (B) to which adenine nucleotides were added as detailed in the text. The high Ca 2+ intracellular solution (solution D) was the same as solution B except that the CaEGTA buffer was adjusted to give 1 p~M free Ca e+. To maintain activity of ATP-sensitive K-channels in inside-out patches we used a protocol based on that of Ohno-shosaku et al. [19] . Patches were excised into an intracellular solution containing 0A mmol/1 ATP+0.1 retool/1 ADP+2 mmol/1 Mg 2+, and a 60 s exposure to this solution was alternated with each test solution. All patches were tested for ATP sensitivity. Test solutions were applied in random order.
In whole-cell experiments the perfusion system allowed the bath solution to be exchanged within 30 s. A micro-superfusion system was used for all excised patch experiments [21] . Experiments were carried out at room temperature 21-23~
Data analysis
For analysis of single channel recordings, current records were amplified (xl0) and low pass filtered using an 8-pole Bessel filter (Frequency Devices, Haverhill, Mass, USA) set at less than half the
Statistical analysis
All data are quoted as mean+ SEM for n observations.
Results
Whole-cell currents
ATP-sensitive K-currents were measured in the wholecell recording configuration using the procedure developed by Trube et al. [5] . The cell was held at -70 mV and hyperpolarizing and depolarizing pulses of 10 mV amplitude and 100 ms duration were applied alternately at a rate of 55 Hz. Most of the resulting current flows through ATP-sensitive K-channels since voltage-dependent currents are not activated by these low pulse amplitudes [22] and activation of Ca-dependent Kchannels [23] was prevented by buffering the free Ca 2+ in the intracellular solution to 0.06 I, tmol/1.
As observed for mouse B cells [5] , following establishment of the whole-cell configuration there was a progressive increase in the current elicited by a 10 mV depolarizing pulse, from an initial value of 0.6 ___ 0.3 pA (n---9) to a maximal amplitude of 87 + 23 pA (n = 9) between 7 and 25 min later. We presume this increase in conductance results from dialysis of ATP from the cell interior leading to activation of ATP-sensitive K-channels.
The maximal conductance remained relatively stable when the intracellular solution contained 0.3 mmol/1 ATP but in most cases subsequently declined in amplitude if ATP was omitted. This is also the case for rodent B cells [5] and probably reflects the rundown of the ATP-sensitive K-channel in nucleotide-free solutions. There did not appear to be a significant block of whole-cell currents by 0.3 mmol/1 ATP as the maximum washout currents were 10.4_+ 3.2 pA/picofarad (pF) (n=4) and ll.l+l.6pA/pF (n=5) for solutions containing 0 mmol/1 ATP and 0.3 mmol/1 ATP, respectively.
The average capacitance of the human B cell was 7.6 + 1.1 pF (n= 9).
Effects of external tolbutamide on whole-cell currents
Sulphonylureas increase plasma insulin levels in man [24] , stimulate insulin release from isolated rodent islets [25] and inhibit the ATP-sensitive K-channels of rodent 593 B cells [5] . It has therefore been postulated that the ability of these drugs to stimulate insulin release in man results from inhibition of the ATP-sensitive K-channel.
We tested the effect of the sulphonylurea tolbutamide on whole-cell ATP-sensitive K-currents once the washout current had reached a stable amplitude. Tolbutamide reversibly decreased both the current response to a 10 mV voltage pulse and the holding current required to maintain the cell at -70 mV (Fig. 1 A) . High concentrations of the drug (1 mmol/1) were not always fully reversible. Tolbutamide inhibition was associated with B cell depolarization, the zero current potential reversibly shifting from -76 to -69 mV (n= 3) in the presence of 1 mmol/1 tolbutamide.
The relationship between tolbutamide concentration and the whole-cell current is shown in Figure 1 B. The line through the data points was calculated according to equation 1 (as described in the Methods) using a Hill co-efficient of 1 and taking Ki, the concentration required for half-maximal inhibition, as 18 p~mol/1. This result is similar to those found for rodent B cells, where a Hill co-efficient of 1 and values for Ki of 7 lxmol/1 [5] , 17 btmol/1 [4] and 4 btmol/1 [7] are reported.
Effects of A TP on single channel currents
As previously described for rodent B cells and B cell lines [17] [18] [19] , intracellular ATP has a dual effect on channel activity in the human B cell; it both inhibits the channel and is required to maintain channel activity.
Following excision of an inside-out patch into nucleotide-free solution, channel activity initially increases, indicating that the ATP-sensitive K-channel is subject to resting inhibition in the intact cell, even in glucose-free solution. Subsequently, the channel activity declines again, a process known as rundown. In rodent B cells, rundown of channel activity can be prevented by intermittent exposure of the patch to phosphorylating solutions containing MgATP [17] [18] [19] . To study the inhibitory effect of ATP on channel activity in human B-cells we used a protocol similar to that described by Ohno-shosaku et al. [19] , alternating test solutions (15-20 s) with a 60 s exposure to a control solution containing 0.1 retool/1 ATP, 0.1 retool/1 ADP and 2 mmol/1 Mg 2+. To control for any residual rundown, channel activity in the test solution was expressed as a fraction of that in the adjacent control. The relationship between ATP concentration and channel activity is quantified in Figure 2B Comparison of traces a and b in Figure 2A shows that ADP is able to relieve channel inhibition by ATP, as described for rodent B cells [18, 26, 27] . In 4 cells, the mean current measured in a solution containing 0.1 mmol/l ADP+0.1 mmol/1 ATP was reduced by 80.3 + 11% when ADP was removed. Figure 3 A illustrates the inhibitory effect of tolbutamide on ATP-sensitive K-currents recorded in an inside-out patch from a human B cell. The probability density functions show that 100 ~tmol/l tolbutamide does not alter the single channel current amplitude but markedly reduces channel activity. This is in accord with previous observations on rodent B cells [5] .
Inhibition by A TP
Effect of internal tolbutamide on single channel currents
We used the following protocol to construct the dose-response curve for tolbutamMe in the inside-out patch (Fig. 3 B) . The patch was exposed to the sequence: 60 s control solution (intracellular solution containing 0.1 retool/1 ATP, 0.1 mmol/l ADP, 2 mmol/1 Mg~+), 15s nucleotide-free intracellular solution, then to nucleotide-free solution containing; tolbutamide (15 s) and finally to nucleotide-free solution again. This sequence was then repeated with a different tolbutamide concentration. The mean current in the presence of the drug (/) was then plotted as a function of the average of the mean current recorded in nucleotide-free solution before and after drug application (It).
It is clear that the channel is far less sensitive to tolbutamide applied to the internal membrane surface than when the drug is applied externally to an intact cell: in the inside-out patch configuration more than 100 ~tmol/1 tolbutamide was required for 50% inhibition (compare 18 ~tmol/1, Fig. 1 B) . In one experiment in which tolbutamide was tested in the presence of 0.1 retool/1 ATP and 0.1 mmol/1 ADP, however, the tolbutamide sensitivity more closely approximated that of the whole-cell recordings (data not shown).
Ca-activated K-channel
In addition to ATP-sensitive K-currents we also observed a Ca-activated K-channel in patches excised from human B cells (Fig. 4) . This channel was studied in nucleotide-free solution after the rundown of ATP-sensitive K-currents. Figure 4A shows a typical recording of channel activity at-60 mV in an intracellular solution containing 10 -6 mol/1 Ca 2+ and that this activity is The open probability is also voltage-dependent, being increased by depolarisation (Fig.5) . Single channel currents recorded at different membrane 
Specificity of tolbutamide action
The Ca-activated K-channel of the rodent B cell is insensitive to high concentrations of tolbutamide [5] , suggesting that inhibition of this channel is not involved in the therapeutic action of the drug. This is also the case for the human B cell. Figure 5 shows that tolbutamide selectively blocks ATP-sensitive K-currents without affecting Ca-activated K-currents in the same patch. The membrane was stepped alternately from -60 mV to +60 mV as shown in the lowest trace. At -60 mV, Ca-activated K-channels are not open (free Ca 2+ < 0.1 ~tmol/1) and only ATP-sensitive K-channels are active. These openings are inward. Ca-activated Kchannels open in response to depolarization to + 60 mY and openings are outward as the driving force for K + is now reversed. Figure 5 shows that even 10 mmol/1 tolbutamide was without effect on Ca-activated K-currents whilst abolishing ATP-sensitive K + channels.
Discussion
A rough estimate of the number of ATP-sensitive Kchannels per human B cell can be obtained by combining the results of the whole-cell and single channel experiments. The maximum wash-out conductance in whole-cell recordings was approximately 10 nS. If we presume the single channel conductance to be about 20 pS in normal extracellular K +, as it is in rodent B cells [5, 28] , we obtain 500 ATP-sensitive K-channels per B cell. This must be considered a lower estimate: the actual number of channels will be undoubtably be higher since it is likely that the channel open probability is much less than one. The ATP-sensitivity of the channel from human B cells measured in the inside-out patch resembles that of the rodent, with a K i for total ATP of around 10 ~tmol/1. Although more than 95% of channel activity was inhibited by 0.3 retool/1 ATP in inside-out patches, in whole-cell recordings this concentration of ATP had no significant blocking effect. A similar discrepancy in ATP-sensitivity between inside-out patches and wholecell recordings has also been reported for rodent B cells [5] and for cardiac muscle [29, 30] . It seems possible that the difference may be partly due to hydrolysis of ATP to ADP in the whole-cell configuration, which would result in a decrease in the ATP/ADP ratio.
Like the rodent B cell, [18, 26, 27] , the blocking effect of ATP in man is partly antagonised by ADP. Indeed, channel activity in the presence of 100 p.mol/1 ATP is increased roughly 5-fold by the addition of a similar concentration of ADP. This suggests that the ATP/ADP ratio is a more important regulator of channel activity than ATP.
The percentage of ATP-sensitive K-channels activated under physiological conditions in the intact human B cell is very low. In whole-cell recordings the input conductance increased approximately 200-fold from an initial value of less than 50 pS to around 10 nS.
This implies that less than 0.5% of channels are activated in the intact cell under physiological conditions. The ATP concentration corresponding to this amount of channel activity is 0.1 mmol/1 (Fig. 2) . The increase in channel activity seen on patch excision is also consistent with significant channel inhibition in the unstimulated B cell.
Tolbutamide inhibited whole-cell washout currents half maximally at 18 [xmol/1 (Fig.3 B) , a value close to that found in rodent B-cells (7 p~mol/1, [5] ; 17 lxmol/1, [4] ; 4 ~tmol/l, [7] ). This concentration is well within the range of therapeutic plasma levels of free tolbutamide [24] . The tolbutamide sensitivity of the ATP-sensitive Kchannel in human B cells supports previous suggestions that the therapeutic action of sulphonylureas is mediated through inhibition of this channel.
Tolbutamide was considerably less effective in inhibiting channel activity in inside-out patches. Since the drug is lipid soluble it seems unlikely that access to the site of action accounts for this discrepancy; rather we believe it may result from a difference in the intracellular solutions used for the two recording configurations. Several studies of rodent B cells have shown that ATP does not affect the sensitivity of the channel to tolbutamide [4, 6, 7] so a direct effect of the 0.3 mmol/1ATP included in the intracellular solution used in whole-cell recordings is not indicated. Instead, it seems probable that the discrepancy is related to the lack of intracellular ADP in excised patch recordings, since Zunckler et al.
[201 have shown that cytosolic ADP enhances the channel sensitivity to tolbutamide. Consistent with this hypothesis was the observation that tolbutamide was more effective in one experiment in which the intracellular solution contained 0.1 mmol/1 ADP+ 0.1 mmol/1 ATP. Although in whole-cell recordings, ADP was not included in the pipette solution, it will be formed from hydrolysis of the ATP.
There is good evidence that Type 2 diabetes is assodated with disorders in the secretory function of the B cell which result in the failure of glucose to stimulate insulin release [31] . Although we recognise that Type 2 diabetes has a multiple aetiology, the ability of sulphonylureas to stimulate release in Type 2 diabetic patients suggests that events subsequent to dosing of the ATPsensitive K-channels remain intact [9] . This raises the possibility that in sulphonylurea-sensitive patients the defect in the B cell may be localised to either (1) glucose uptake (2) glucose metabolism or (3) a defect in the channel which alters its ability to respond to glucose metabolism. Clearly, studies on B cells isolated from diabetic donors are required to distinguish between these possibilities. In the absence of such studies it is worth noting that an increase in futile cycles of glucose metabolism causing ATP hydrolysis has been reported for both liver cells [32] and B cells [33] isolated from Type 2 diabetic patients. Furthermore, in fetal B cells, which also manifest an impaired response to glucose, the ATP-and tolbutamide-sensitivity of the ATP-sensifive K-channel is similar to that of the adult but the sugar both fails to increase the ATP content or inhibit the channel [34] . These findings lead us to speculate that one of the causes of Type 2 diabetes may be a disturbance of glucose metabolism which results in defective regulation of ATP-sensitive K-channels and thus failure of insulin release.
Finally, we emphasise that we have not yet observed any marked differences in the properties of the human B cell and those of rodent B cells. The sensitivity to tolbutamide is essentially the same; similarly, the ATP sensitivity and its modulation by ADP resemble those of the rodent. Our studies therefore indicate that the rodent B cell provides a good model for that of the human.
